594
Views
0
CrossRef citations to date
0
Altmetric
Acute Kidney Injury

The association between systemic inflammatory response index and contrast-associated acute kidney injury in patients undergoing elective percutaneous coronary intervention

, , , , , , , & show all
Article: 2330621 | Received 09 Nov 2023, Accepted 08 Mar 2024, Published online: 01 Apr 2024

References

  • Section 4: contrast-induced AKI. Kidney Int Suppl (2011). 2012;2(1):1–9. doi: 10.1038/kisup.2011.34.
  • Nash K, Hafeez A, Hou S. Hospital-acquired renal in­sufficiency. Am J Kidney Dis. 2002;39(5):930–936. doi: 10.1053/ajkd.2002.32766.
  • Skalsky K, Levi A, Bental T, et al. The definition of "acute kidney injury" following percutaneous coronary intervention and cardiovascular outcomes. Am J Cardiol. 2021;156:39–43. doi: 10.1016/j.amjcard.2021.06.033.
  • Wi J, Ko YG, Kim JS, et al. Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention. Heart. 2011;97(21):1753–1757. doi: 10.1136/hrt.2010.218677.
  • Zhang F, Lu Z, Wang F. Advances in the pathogenesis and prevention of contrast-induced nephropathy. Life Sci. 2020;259:118379. doi: 10.1016/j.lfs.2020.118379.
  • Karauzum I, Karauzum K, Acar B, et al. Predictive value of lymphocyte-to-monocyte ratio in patients with contrast-induced nephropathy after percutaneous coronary intervention for acute coronary syndrome. J Transl Int Med. 2021;9(2):123–130. doi: 10.2478/jtim-2021-0024.
  • Wu X, Ma C, Sun D, et al. Inflammatory indicators and hematological indices in contrast-Induced nephropathy among patients receiving coronary intervention: a systematic review and Meta-Analysis. Angiology. 2021;72(9):867–877. doi: 10.1177/00033197211000492.
  • Zorlu C, Koseoglu C. Comparison of the relationship between inflammatory markers and contrast-Induced nephropathy in patients with acute coronary syndrome after coronary angiography. Angiology. 2020;71(3):249–255. doi: 10.1177/0003319719892160.
  • Han K, Shi D, Yang L, et al. Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Ann Med. 2022;54(1):1667–1677. doi: 10.1080/07853890.2022.2083671.
  • Jin Z, Wu Q, Chen S, et al. The associations of two novel inflammation indexes, SII and SIRI with the risks for cardiovascular diseases and All-Cause mortality: a Ten-Year follow-up study in 85,154 individuals. J Inflamm Res. 2021;14:131–140. doi: 10.2147/jir.S283835.
  • Li J, He D, Yu J, et al. Dynamic status of SII and SIRI alters the risk of cardiovascular diseases: evidence from kailuan cohort study. J Inflamm Res. 2022;15:5945–5957. doi: 10.2147/jir.S378309.
  • Mehran R, Dangas GD, Weisbord SD. Contrast-Associated acute kidney injury. N Engl J Med. 2019;380(22):2146–2155. doi: 10.1056/NEJMra1805256.
  • Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145(4):247–254. doi: 10.7326/0003-4819-145-4-200608150-00004.
  • Goldenberg I, Matetzky S. Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. CMAJ. 2005;172(11):1461–1471. doi: 10.1503/cmaj.1040847.
  • Akcay A, Nguyen Q, Edelstein CL. Mediators of inflammation in acute kidney injury. Mediators Inflamm. 2009;2009:137072–137012. doi: 10.1155/2009/137072.
  • Bansal S, Patel RN. Pathophysiology of contrast-Induced acute kidney injury. Interv Cardiol Clin. 2020;9(3):293–298. doi: 10.1016/j.iccl.2020.03.001.
  • Tucker B, Vaidya K, Cochran BJ, et al. Inflammation during percutaneous coronary intervention-Prognostic value, mechanisms and therapeutic targets. Cells. 2021;10(6):1391. doi: 10.3390/cells10061391.
  • Yuan Y, Qiu H, Hu X, et al. Predictive value of inflammatory factors on contrast-induced acute kidney injury in patients who underwent an emergency percutaneous coronary intervention. Clin Cardiol. 2017;40(9):719–725. doi: 10.1002/clc.22722.
  • Tanık VO, Çınar T, Velibey Y, et al. Neutrophil-to-lymphocyte ratio predicts contrast-Induced acute kidney injury in patients with ST-Elevation myocardial infarction treated with primary percutaneous coronary intervention. J Tehran Heart Cent. 2019;14(2):59–66.
  • Fan Z, Li Y, Ji H, et al. Prognostic utility of the combination of monocyte-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with NSTEMI after primary percutaneous coronary intervention: a retrospective cohort study. BMJ Open. 2018;8(10):e023459. doi: 10.1136/bmjopen-2018-023459.
  • Chen L, Chen Y, Zhang L, et al. In gastric cancer patients receiving neoadjuvant chemotherapy systemic inflammation response index is a useful prognostic indicator. Pathol Oncol Res. 2021;27:1609811. doi: 10.3389/pore.2021.1609811.
  • Xu Y, He H, Zang Y, et al. Systemic inflammation response index (SIRI) as a novel biomarker in patients with rheumatoid arthritis: a multi-center retrospective study. Clin Rheumatol. 2022;41(7):1989–2000. doi: 10.1007/s10067-022-06122-1.
  • Zhang Y, Xing Z, Zhou K, et al. The predictive role of systemic inflammation response index (SIRI) in the prognosis of stroke patients. Clin Interv Aging. 2021;16:1997–2007. doi: 10.2147/cia.S339221.
  • Li Q, Ma X, Shao Q, et al. Prognostic impact of multiple lymphocyte-based inflammatory indices in acute coronary syndrome patients. Front Cardiovasc Med. 2022;9:811790. doi: 10.3389/fcvm.2022.811790.
  • Biyik M, Biyik Z, Asil M, et al. Systemic inflammation response index and systemic immune inflammation index are associated with clinical outcomes in patients with acute pancreatitis? J Invest Surg. 2022;35(8):1613–1620. doi: 10.1080/08941939.2022.2084187.
  • Tokarek T, Dziewierz A, Plens K, et al. Percutaneous coronary intervention during on- and off-hours in patients with ST-segment elevation myocardial infarction. Hellenic J Cardiol. 2021;62(3):212–218. doi: 10.1016/j.hjc.2021.01.011.